NL-OMON56632招募中不适用
AntiPhosphoLipid antibodies and point-of-care INR measurement with CoaguChek - VervOlg Studie - APLIVOS
niversitair Medisch Centrum Utrecht0 个研究点目标入组 44 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Age 18 years and older
- •- Previously confirmed APS, diagnosed in accordance with the Sydney criteria
- •- High titers of anti-B2-glycoprotein-I IgG at screening (titer > 99th
- •percentile)
- •- Lupus anticoagulant positive at screening
- •- Receiving VKA during at least 3 months
- •- At least one thromboembolic event in the past
- •- Willing and be able to understand the study information and sign the informed
- •consent form
排除标准
- •Patients with only obstetric complications of antiphospholipid syndrome without
- •thrombotic events
研究者
相似试验
尚未招募
不适用
Antiphospholipid Antibody (APLA) level in COVID-19 Cases.CTRI/2020/06/026118DR Rajlaxmi Sarangi
尚未招募
不适用
The influence of antiphospholipid antibodies on INR values measured with the CoaguChek XSNL-OMON21805Dutch Thrombosis Foundation80
已完成
不适用
The influence of antiphospholipid antibodies on INR values measured with the CoaguChek XSNL-OMON51121niversitair Medisch Centrum Utrecht80
进行中（未招募）
不适用
Antiphospholipid antibodies testing and pregnancy outcomes in recurrent implantation failure women, is it necessary?Recurrent implantation failure womenRecurrent implantation failureAntiphospholipid antibodiesICSITCTR20231003007/A250
Unknown
不适用
Presence of Minor Anti Phospholipid Antibodies in Blood Samples of Ischemic Stroke Patients and Healthy ControlsIschemic StrokeNCT01487746Meir Medical Center207